Accumulation of p53 in a Mutant Cell Line Defective in the Ubiquitin Pathway

REFERENCES

• Agoff, S. N., J. Hou, D. I. H. Linzer, and B. Wu. 1993. Regulation of the human hsp70 promoter by p53. Science 259:84–87.
   PubMed Web of Science ®Google Scholar
• Baker, S. J., S. Markowitz, E. R. Fearon, J. K. U. Willson, and B. Vogelstein. 1990. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912–915.
   PubMed Web of Science ®Google Scholar
• Barak, Y., and M. Oren. 1992. Enhanced binding of a 95 kDa protein to p53 in cells undergoing p53-mediated growth arrest. EMBO J. 11:2115–2121.
   PubMed Web of Science ®Google Scholar
• Bargonetti, J., P. N. Friedman, S. E. Kern, B. Vogelstein, and C. Prives. 1991. Wild-type but not mutant immunopurified proteins bind to sequences adjacent to the SV40 origin of replication. Cell 65:1083–1091.
   PubMed Web of Science ®Google Scholar
• Bernard, H.-U., G. Krammer, and W. G. Rowekamp. 1985. Construction of a fusion gene that confers resistance against hygromycin B to mammalian cells in culture. Exp. Cell Res. 158:237–243.
   PubMedGoogle Scholar
• Ceichanover, A., J. A. DiGiuseppe, B. Bercovich, A. Orian, J. D. Richter, A. L. Schwartz, and G. M. Brodeur. 1991. Degradation of nuclear oncoproteins by the ubiquitin proteolysis system in vitro. Proc. Natl. Acad. Sci. USA 88:139–143.
   PubMedGoogle Scholar
• Davie, J. R., and L. C. Murphy. 1990. Level of ubiquitinated histone H2B in chromatin is coupled to ongoing transcription. Biochemistry 29:4752–4757.
   PubMed Web of Science ®Google Scholar
• Dermody, J. J., K. G. Lawlor, H. Du, B. E. Wojcik, K. K. Jha, L. Malkas, R. Hickey, E. F. Baril, and H. L. Ozer. 1988. Polyomavirus DNA synthesis in vitro: studies with CHO, 3T3 and their ts DNA mutants. Cancer Cells 6:95–100.
   Google Scholar
• Dermody, J. J., B. E. Wojcik, H. Du, and H. L. Ozer. 1986. Identification of temperature-sensitive DNA- mutants of Chinese hamster cells affected in cellular and viral DNA synthesis. Mol.Cell. Biol. 6:4594–4601.
   PubMedGoogle Scholar
• Donehower, L. A., M. Harvey, B. L. Slagle, M. J. McArthur, C. A. Montgomery, J. S. Butel, and A. Bradley. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature (London) 356:215–221.
   PubMed Web of Science ®Google Scholar
• Eliyahu, D., D. Michalovitz, S. Eliyahu, O. Pinhasi-Kimhi, and M. Oren. 1989. Wild-type p53 can inhibit oncogene-mediated focus formation. Proc. Natl. Acad. Sci. USA 86:8763–8767.
   PubMed Web of Science ®Google Scholar
• Ellison, K. S., T. Gwozd, J. A. Prendergast, M. C. Paterson, and M. J. Ellison. 1991. Site directed approach for constructing temperature-sensitive ubiquitin-conjugating enzymes reveals a cell cycle function and growth for RAD6. J. Biol. Chem. 266:24116–24120.
   PubMedGoogle Scholar
• Fakharzadeh, S. S., S. P. Trusko, and D. L. George. 1991. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J. 10:1565–1569.
   PubMed Web of Science ®Google Scholar
• Finlay, C. A., P. W. Hinds, and A. J. Levine. 1989. The p53 proto-oncogene can act as a suppressor of transformation. Cell 57:1083–1093.
   PubMed Web of Science ®Google Scholar
• Funk, W. D., D. T. Pak, R. H. Karas, W. E. Wright, and J. W. Shay. 1992. A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol. 12:2866–2871.
   PubMed Web of Science ®Google Scholar
• Gannon, J. V., R. Greaves, R. Iggo, and D. P. Lane. 1990. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J. 9:1595–1602.
   Google Scholar
• Glotzer, M., A. W. Murray, and M. W. Kirschner. 1991. Cyclin is degraded by the ubiquitin pathway. Nature (London) 349:132–138.
   PubMed Web of Science ®Google Scholar
• Goebl, M. G., J. Yochem, S. Jentsch, J. P. McGrath, A. Varshavsky, and B. Byers. 1988. The yeast cell cycle gene CDC34 encodes a ubiquitin-conjugating enzyme. Science 241:1331–1335.
   PubMed Web of Science ®Google Scholar
• Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456–467.
   PubMed Web of Science ®Google Scholar
• Gronostajski, R. M., A. L. Goldberg, and A. B. Pardee. 1984. Energy requirement for degradation of tumor-associated protein p53. Mol. Cell. Biol. 4:442–448.
   PubMedGoogle Scholar
• Handley, P. M., M. Mueckler, N. R. Siegel, A. Ceichanover, and A. L. Schwartz. 1991. Molecular cloning, sequence, and tissue distribution of the human ubiquitin-activating enzyme El. Proc. Natl. Acad. Sci. USA 88:258–262.
   PubMed Web of Science ®Google Scholar
• Harlow, E., L. V. Crawford, D. C. Pim, and N. H. Williamson. 1981. Monoclonal antibodies specific for simian virus 40 tumor antigens. J. Virol. 39:861–869.
   PubMed Web of Science ®Google Scholar
• Hartwell, L. 1992. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71:543–546.
   PubMed Web of Science ®Google Scholar
• Hershko, A., and A. Ceichanover. 1992. The ubiquitin system for protein degradation. Annu. Rev. Biochem. 61:761–807.
   PubMed Web of Science ®Google Scholar
• Hinds, P. W., C. A. Finlay, A. B. Frey, and A. J. Levine. 1987. Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines. Mol. Cell. Biol. 7:2863–2869.
   PubMed Web of Science ®Google Scholar
• Hupp, T. R., D. W. Meek, C. A. Midgley, and D. P. Lane. 1992. Regulation of the specific DNA binding function of p53. Cell 71:875–886.
   PubMed Web of Science ®Google Scholar
• Jha, K. K., M. Siniscalco, and H. L. Ozer. 1980. Temperaturesensitive mutants of Balb/3T3 cells. III. Hybrids between ts2 and other mouse mutant cells affected in DNA synthesis and correction of ts2 defect by human X chromosome. Somatic Cell Genet. 6:603–614.
   Google Scholar
• Kern, S. E., K. W. Kinzler, A. Bruskin, D. Jarosz, P. N. Friedman, C. Prives, and B. Vogelstein. 1991. Identification of p53 as a sequence-specific DNA-binding protein. Science 252:1708–1711.
   PubMed Web of Science ®Google Scholar
• LaBella, F., and H. L. Ozer. 1985. Differential replication of SV40 and polyoma DNAs in Chinese hamster ovary cells. Virus Res. 2:329–343.
   PubMedGoogle Scholar
• Lane, D. P., and S. Benchimol. 1990. p53, oncogene or protooncogene? Genes Dev. 4:1–8.
   PubMed Web of Science ®Google Scholar
• Levine, A. J., J. Momand, and C. A. Finlay. 1991. The p53 tumor suppressor gene. Nature (London) 351:453–456.
   PubMed Web of Science ®Google Scholar
• Lin, J.-Y., and D. T. Simmons. 1991. The ability of large T antigen to complex with p53 is necessary for the increased life span and partial transformation of human cells by simian virus 40. J. Virol. 65:6447–6453.
   PubMedGoogle Scholar
• Malkas, L. 1985. Ph.D. thesis. The City University of New York, New York, N.Y.
   Google Scholar
• Malkin, D., F. P. Li, L. C. Strong, J. F. Fraumeni, C. E. Nelson, D. H. Kim, J. Kassel, M. A. Gryka, F. Z. Bischoff, M. A. Tainsky, and S. Friend. 1990. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233–1238.
   PubMed Web of Science ®Google Scholar
• Manfredi, J. J., and C. Prives. 1990. Binding of p53 and p105-RB is not sufficient for oncogenic transformation by a hybrid polyomavirus-simian virus 40 large T antigen. J. Virol. 64:5250–5259.
   PubMedGoogle Scholar
• McGrath, J. P., S. Jentsch, and A. Varshavsky. 1991. UBA1: an essential yeast gene encoding ubiquitin-activating enzyme. EMBO J. 10:227–236.
   PubMed Web of Science ®Google Scholar
• Michalovitz, D., O. Halevy, and M. Oren. 1990. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62:671–680.
   PubMed Web of Science ®Google Scholar
• Michalovitz, D., O. Halevy, and M. Oren. 1991. p53 mutations: gains or losses? J. Cell. Biochem. 45:22–29.
   PubMed Web of Science ®Google Scholar
• Milner, J., and E. A. Medcalf. 1990. Temperature-dependent switching between “wild type” and “mutant” forms of p53-val135. J. Mol. Biol. 216:481–484.
   PubMed Web of Science ®Google Scholar
• Momand, J., G. P. Zambetti, D. C. Olson, D. George, and A. J. Levine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237–1245.
   PubMed Web of Science ®Google Scholar
• Mulligan, R. C., and P. Berg. 1981. Selection for animal cells that express the E. coli gene coding for xanthine-guanine phosphoribosyltransferase. Proc. Natl. Acad. Sci. USA 78:2072–2076.
   PubMed Web of Science ®Google Scholar
• Oliner, J. D., K. W. Kinzler, P. S. Meltzer, D. L. George, and B. Vogelstein. 1992. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature (London) 358:80–85.
   PubMed Web of Science ®Google Scholar
• Oren, M., W. Maltzman, and A. J. Levine. 1981. Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol. Cell. Biol. 1:101–110.
   PubMed Web of Science ®Google Scholar
• Pinhasi-Kimhi, O., D. Michalovitz, A. Ben-Zeev, and M. Oren. 1986. Specific interaction between the p53 cellular tumor antigen and major heat shock proteins. Nature (London) 320:182–185.
   PubMed Web of Science ®Google Scholar
• Radna, R. L., B. Foellmer, L. A. Feldman, U. Francke, and H. L. Ozer. 1987. Restriction of human adenovirus replication in Chinese hamster cell lines and their hybrids with human cells. Virus Res. 8:277–299.
   PubMedGoogle Scholar
• Reihsaus, E., M. Kohler, S. Kraiss, M. Oren, and M. Montenarh. 1990. Regulation of the level of the oncoprotein p53 in nontransformed and transformed cells. Oncogene 5:137–145.
   PubMed Web of Science ®Google Scholar
• Resnick-Silverman, L., Z. Pang, G. Li, K. K. Jha, and H. L. Ozer. 1991. Retinoblastoma protein and simian virus 40-dependent immortalization of human fibroblasts. J. Virol. 65:2845–2852.
   PubMedGoogle Scholar
• Rogers, S., R. Wells, and M. Rechsteiner. 1986. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234:364–368.
   PubMed Web of Science ®Google Scholar
• Sarnow, P., Y. S. Ho, J. Williams, and A. J. Levine. 1982. Adenovirus Elb-58 kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell 28:387–394.
   PubMed Web of Science ®Google Scholar
• Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus type 16 and 18 promotes degradation of p53. Cell 63:1129–1136.
   PubMed Web of Science ®Google Scholar
• Seto, E., A. Usheva, G. P. Zambetti, J. Momand, N. Horikoshi, R. Weinmann, A. J. Levine, and T. Shenk. 1992. Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc. Natl. Acad. Sci. USA 89:12028–12032.
   PubMed Web of Science ®Google Scholar
• Slater, M. L., and H. L. Ozer. 1976. Temperature-sensitive mutants of Balb/3T3 cells: description of a mutant affected in cellular and polyoma DNA synthesis. Cell 7:289–295.
   PubMedGoogle Scholar
• Southern, P. J., and P. Berg. 1982. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:327–324.
   PubMedGoogle Scholar
• Stürzbecher, H.-W., C. Addison, and J. R. Jenkins. 1988. Characterization of mutant p53-hsp72/73 protein-protein complexes by transient expression in monkey COS cells. Mol. Cell. Biol. 8:3740–3747.
   PubMed Web of Science ®Google Scholar
• Sturzbecher, H.-W., P. Chumakov, W. J. Welch, and J. R. Jenkins. 1987. Mutant p53 protein bind hsp 72/73 cellular heat shock- related proteins in SV40-transformed monkey cells. Oncogene 1:201–211.
   PubMed Web of Science ®Google Scholar
• Tevethia, M. J., J. M. Pipas, T. Kirstead, and C. Cole. 1988. Requirements for immortalization of primary mouse embryo fibroblasts probed with mutants bearing deletions in the 3′ end of SV 40 gene A. Virology 162:76–89.
   PubMedGoogle Scholar
• Vogelstein, B., and K. W. Kinzler. 1992. p53 function and dysfunction. Cell 70:523–526.
   PubMed Web of Science ®Google Scholar
• Wiebel, F. F., and W.-H. Kunau. 1992. The Pas2 protein essential for peroxisome biogenesis related to ubiquitin-conjugating enzymes. Nature (London) 359:73–76.
   PubMedGoogle Scholar
• Wigler, M., R. Sweet, G. K. Sim, B. Wold, A. Pellicer, E. Lacy, T. Maniatis, S. Silverstein, and R. Axel. 1979. Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell 16:777–785.
   PubMed Web of Science ®Google Scholar
• Yewdell, J. W., J. V. Gannon, and D. P. Lane. 1986. Monoclonal antibody analysis of p53 expression in normal and transformed cells. J. Virol. 59:444–452.
   PubMed Web of Science ®Google Scholar
• Zacksenhaus, E., and R. Sheinin. 1990. Molecular cloning, primary structure and expression of the human X linked A1S9 gene cDNA which complements the ts A1S9 mouse L cell defect in DNA replication. EMBO J. 9:2923–2929.
   PubMed Web of Science ®Google Scholar
• Zeng, G.-C., J. Donegan, H. L. Ozer, and R. Hand. 1984. Characterization of a ts mutant of BALB/3T3 cells and correction of the defect by in vitro addition of extracts from wild-type cells. Mol. Cell. Biol. 4:1815–1822.
   PubMedGoogle Scholar
• Zhu, J., M. Abate, P. W. Rice, and C. N. Cole. 1991. The ability of simian virus 40 large T antigen to immortalize primary mouse embryo fibroblasts cosegregates with its ability to bind to p53. J. Virol. 65:6872–6880.
   PubMedGoogle Scholar